Jamroz-Wiśniewska A - Search Results

1

Disappearance of white matter lesions on MRI and clinical recovery after initiating antiretroviral therapy in a case of HIV infection presenting as spastic paraparesis.

Jamroz-Wiśniewska A, Jaworski J, Suszek D, Janczarek M, Stelmasiak Z, Rejdak K, Bartosik-Psujek H. Jamroz-Wiśniewska A, et al. Neurol Neurochir Pol. 2014;48(5):378-81. doi: 10.1016/j.pjnns.2014.09.004. Epub 2014 Oct 13. Neurol Neurochir Pol. 2014. PMID: 25440019

2

[Validation of selected aspects of psychometry of the Polish version of the Multiple Sclerosis Impact Scale 29 (MSIS-29)].

Jamroz-Wiśniewska A, Papuć E, Bartosik-Psujek H, Belniak E, Mitosek-Szewczyk K, Stelmasiak Z. Jamroz-Wiśniewska A, et al. Neurol Neurochir Pol. 2007 May-Jun;41(3):215-22. Neurol Neurochir Pol. 2007. PMID: 17629814 Polish.

3

Tumour-like lesions in multiple sclerosis.

Jamroz-Wiśniewska A, Janczarek M, Belniak E, Stelmasiak Z, Bartosik-Psujek H. Jamroz-Wiśniewska A, et al. Neurol Neurochir Pol. 2008 Mar-Apr;42(2):161-7. Neurol Neurochir Pol. 2008. PMID: 18512174

4

Paraoxonase 1 activity in different types of multiple sclerosis.

Jamroz-Wisniewska A, Beltowski J, Stelmasiak Z, Bartosik-Psujek H. Jamroz-Wisniewska A, et al. Mult Scler. 2009 Mar;15(3):399-402. doi: 10.1177/1352458508098371. Epub 2008 Oct 9. Mult Scler. 2009. PMID: 18845659

5

Validation analysis of the Polish version of the Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL).

Jamroz-Wiśniewska A, Stelmasiak Z, Bartosik-Psujek H. Jamroz-Wiśniewska A, et al. Neurol Neurochir Pol. 2011 May-Jun;45(3):235-44. doi: 10.1016/s0028-3843(14)60076-1. Neurol Neurochir Pol. 2011. PMID: 21866480

6

Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapy.

Jamroz-Wisniewska A, Beltowski J, Stelmasiak Z, Bartosik-Psujek H. Jamroz-Wisniewska A, et al. Acta Neurol Scand. 2013 Jun;127(6):e33-6. doi: 10.1111/ane.12000. Epub 2012 Aug 11. Acta Neurol Scand. 2013. PMID: 22881373

7

Processes of plasma protein N-homocysteinylation in multiple sclerosis.

Jamroz-Wiśniewska A, Bełtowski J, Bartosik-Psujek H, Wójcicka G, Rejdak K. Jamroz-Wiśniewska A, et al. Int J Neurosci. 2017 Aug;127(8):709-715. doi: 10.1080/00207454.2016.1241782. Epub 2016 Oct 14. Int J Neurosci. 2017. PMID: 27671515

8

Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients.

Jamroz-Wiśniewska A, Bełtowski J, Wójcicka G, Bartosik-Psujek H, Rejdak K. Jamroz-Wiśniewska A, et al. Oxid Med Cell Longev. 2020 Mar 14;2020:1654754. doi: 10.1155/2020/1654754. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32256946 Free PMC article.

9

Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors.

Sapko K, Jamroz-Wiśniewska A, Marciniec M, Kulczyński M, Szczepańska-Szerej A, Rejdak K. Sapko K, et al. Neurol Neurochir Pol. 2020;54(3):252-258. doi: 10.5603/PJNNS.a2020.0037. Epub 2020 May 28. Neurol Neurochir Pol. 2020. PMID: 32462652 Review.

10

A comment on the paper 'Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors' by Sapko et al.

Sapko K, Jamroz-Wiśniewska A, Marciniec M, Kulczyński M, Szczepańska-Szerej A, Rejdak K. Sapko K, et al. Neurol Neurochir Pol. 2021;55(1):117. doi: 10.5603/PJNNS.a2020.0075. Epub 2020 Oct 7. Neurol Neurochir Pol. 2021. PMID: 33026645 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters